文献速递妇科

一种用于改善宫颈鳞状细胞癌预后预测的15个长链非编码RNA特征

A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
PubMed 文献 · Gynecol Oncol · 2018-03-08

本研究从TCGA数据库收集长链非编码RNA(lncRNA)表达谱,识别与宫颈鳞状细胞癌预后相关的lncRNA,并基于Cox回归系数构建15-lncRNA风险评分,通过ROC分析确定最佳截断点,在完整集和内部测试集中验证其预后价值。

要点

  • 从TCGA数据库识别并验证了由15个lncRNA组成的预后特征。
  • 基于Cox系数构建风险评分,ROC分析确定最佳截断点划分风险等级。
  • 该15-lncRNA特征可预测宫颈鳞状细胞癌患者生存。

核心结论

  • 识别并验证了一个15-lncRNA表达特征,可预测宫颈鳞状细胞癌患者的生存。
  • 该特征及单个lncRNA作为宫颈癌预后靶点的潜在功能在本研究中被揭示。

研究设计与样本

  • 从TCGA数据库收集宫颈鳞状细胞癌的lncRNA表达谱。
  • 基于单个lncRNA的Cox回归系数构建15-lncRNA风险评分。
  • 采用ROC分析确定划分患者风险等级的最佳截断点。
  • 在完整集和内部测试集中验证风险评分的预后价值。

主要发现

  • 构建的15-lncRNA特征包含BAIAP2-AS1、RP11-203J24.8、LINC01133、RP1-7G5.6、RP11-147L13.15、SERHL、CTC-537E7.3、RP11-440L14.1、RP11-131N11.4、ILF3-AS1、RP11-80H18.4、RP11-1096G20.5、CTD-2192J16.26、RP11-621L6.3和RP11-571M6.18。
  • 该15-lncRNA风险评分的预后价值在完整集和内部测试集中得到验证。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Long non-coding RNAs (lncRNAs), which have little or no protein-coding capacity, caught a particular interest since their potential roles in the cancer paradigm. As the most common cancer in women, cervical squamous cell carcinoma remains one of the leading causes of deaths from cancer. However, limited evidence is available to determine the role of lncRNAs in the prognosis of cervical squamous cell carcinoma. In this study, we collected lncRNA expression profiling to identify prognosis related lncRNAs for cervical squamous cell carcinoma from TCGA database. In addition, we developed a 15-lncRNA signature based risk score to comprehensively assess the prognostic function of lncRNA. Furthermore, we performed a ROC analysis to identify the optimal cut-off point for classification risk level of the patients. Univariate Cox regression models were used to assess the association between lncRNAs and prognosis of patients with cervical squamous cell carcinoma. A 15-lncRNA based risk score was developed based on the Cox co-efficient of the individual lncRNAs. The prognostic value of this risk score was validated in the complete set and internal testing set. In summary, a 15-lncRNA expression signature (BAIAP2-AS1, RP11-203J24.8, LINC01133, RP1-7G5.6, RP11-147L13.15, SERHL, CTC-537E7.3, RP11-440L14.1, RP11-131N11.4, ILF3-AS1, RP11-80H18.4, RP11-1096G20.5, CTD-2192J16.26, RP11-621L6.3, and RP11-571M6.18) were identified and validated which can predict cervical cancer patient survival. The potential functions of this 15-lncRNA expression signature and individual lncRNAs as prognostic targets of cervical cancer were revealed by this study. Furthermore, these findings may have important implications in the understanding of the potential therapeutic method for the cervical squamous cell carcinoma patients.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Mao X, Qin X, Li L, et al. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma. Gynecol Oncol. 2018. PMID: 29525275. doi:10.1016/j.ygyno.2017.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。